Lung Cancer Trials Ask AI to find trials
Active Not RecruitingNot applicableNCT04761107
Official study title

Impact of COVID-19 on GU Disease

Study summary

The purpose of this research study is to identify patients with GU disease with active or past COVID-19 infection. Participants will be asked to: * Complete an Online COVID-19 Questionnaire. * Disclose if the patient has or had Genitourinary cancer or benign urologic condition * Provide urine specimen for research * Provide 4 tablespoons of blood for testing blood for research. * Provide permission to access medical records, such as patient lab results, medical history, imaging reports, etc.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedNot specified

The study team can explain what participation involves.

Who it may be forCOVID-19 Infection · Genitourinary Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jan 31, 2025 · Source: ClinicalTrials.gov

Is enrollment open?Active Not Recruiting

The study is underway but is not accepting new participants.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Icahn School of Medicine at Mount Sinai

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Icahn School of Medicine at Mount Sinai
Interventions being studied
Not specified
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Subjects must be men and women 40 years of age or older
  • Subjects at risk or with GU cancer (Prostate, Bladder, Kidney)
  • Subjects with benign GU disorders ( BPH, UTI, Bladder infection and kidney stone)
  • Subjects must have a GU disease that requires clinic visit as determined by physician or healthcare provider following a telehealth appointment
  • Willing and able to provide blood and urine samples
  • Willing and able to complete a questionnaire to determine the COVID-19 symptoms.
  • Willing and able to sign informed consent form
Reasons someone may not be able to joinExclusion criteria
  • Men and women below 40 years of age
  • Subjects do not have a GU disease

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Icahn School of Medicine at Mount SinaiNew York, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jan 31, 2025. Always confirm current availability with the study team.

View original record ↗